首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   102869篇
  免费   10464篇
  国内免费   5994篇
耳鼻咽喉   785篇
儿科学   896篇
妇产科学   1367篇
基础医学   29118篇
口腔科学   3217篇
临床医学   6706篇
内科学   13949篇
皮肤病学   2046篇
神经病学   7859篇
特种医学   1955篇
外国民族医学   23篇
外科学   8365篇
综合类   15420篇
现状与发展   21篇
一般理论   2篇
预防医学   2744篇
眼科学   2813篇
药学   10283篇
  14篇
中国医学   3165篇
肿瘤学   8579篇
  2024年   128篇
  2023年   1099篇
  2022年   2006篇
  2021年   3119篇
  2020年   3029篇
  2019年   2690篇
  2018年   2812篇
  2017年   3305篇
  2016年   3803篇
  2015年   4288篇
  2014年   6496篇
  2013年   8135篇
  2012年   6271篇
  2011年   7287篇
  2010年   5918篇
  2009年   5671篇
  2008年   5960篇
  2007年   5936篇
  2006年   5457篇
  2005年   4697篇
  2004年   3959篇
  2003年   3229篇
  2002年   2458篇
  2001年   2085篇
  2000年   1810篇
  1999年   1574篇
  1998年   1483篇
  1997年   1386篇
  1996年   1247篇
  1995年   1312篇
  1994年   1162篇
  1993年   1020篇
  1992年   830篇
  1991年   792篇
  1990年   670篇
  1989年   668篇
  1988年   558篇
  1987年   518篇
  1986年   447篇
  1985年   677篇
  1984年   602篇
  1983年   429篇
  1982年   525篇
  1981年   401篇
  1980年   340篇
  1979年   302篇
  1978年   205篇
  1977年   160篇
  1976年   144篇
  1975年   54篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Smooth muscle cells have been isolated from human umbilical cord veins, characterized and cultured for the development of an endothelialsmooth muscle cell co-culture system. After harvesting endothelial cells, the umbilical cords were trimmed of amnion, connective tissue and arteries, split into pieces, cut open longitudinally and placed with the luminal surface of the explant down onto a culture plate, without the use of proteolytic enzymes. Adherent primary cells were sequentially passaged and various cytological/biochemical characterizations were performed between passages 2 and 10. Cells stained positive for antibodies against smooth muscle actin, negative for antibodies against factor VIII and displayed typical hill and valley morphology when confluent. Cell proliferation was stimulated and supported in a concentration-dependent manner by both human serum and fetal bovine serum over the range 1%–20%. The use of human serum at concentrations >10% decreased the population doubling time during exponential growth by circa 50%. The cells were also characterized by high seeding efficiencies (>70%) and retained their diploid karyotype for up to 3 months in culture. Endothelial cells and smooth muscle cells prepared from umbilical veins were then seeded at varying densities onto either side of porous tissue culture inserts coated with fibronectin. Utilising the measurement of electrical resistance, the optimal seeding density of 5×104 cells/cm2 for each cell type gave maximal resistance across the cell bi-layer already after 24 hours, which remaining essentially unaltered for up to 4 days of culture and which was always substantially higher than the resistance of filters seeded only with endothelial cells on one side. This was not substantially affected either by increasing passage of the HUVSM cells cultured with a fixed passage of endothelial cells, or by varying the donor origin of the endothelial cells. In terms of functionality of the selective permeability of the model, the calcium ionophore ionomycin (25 M), added to the endothelial side of the bi-layer, caused a 30% reduction in the electrical resistance across the co-culture within 60 minutes, with control resistance being re-established within 1 hour of removal of the ionophore by washing. These results clearly indicate that smooth muscle cells and endothelial cells prepared from the same human blood vessel can be reconstituted into a functional vascular model suitable for the study of biochemical, physiological and toxicological phenomena in the human vascular wall.Abbreviations BCA bicinchoninic acid - BSA bovine serum albumin - DMEM DMEM medium supplemented with 4.5 g/l glucose, 100 IU/ml penicillin, 100 g/ml streptomycin and 1.25 g/ml fungizone - DMEM-1 DMEM supplemented with 20% FBS, 300 IU/ml penicillin, 300 g/ml streptomycin and 3.75 mg/ml fungizone - DMEM-2 DMEM supplemented with 20% FBS, 100 IU/ml of penicillin, 100 g/ml of streptomycin and 1.25 g/ml of fungizone - DMSO dimethyl sulfoxide - FBS fetal bovine serum - HPF human pulmonary fibroblasts - HS human serum - HUVE human umbilical vein endothelial - HUVSM human umbilical vein smooth muscle - M199 M199 medium supplemented with 20% HS, 100 IU/ml penicillin, 100 g/ml streptomycin, 1.25 g/ml fungizone and 2 mM L-glutamine - P passage number - PBS phosphate buffered saline - TCA trichloroacetic acid - vwF von Willebrand factor (factor VIII)  相似文献   
992.
We examined the effects of enclomiphene and zuclomiphene, aloneand in combination with oestradiol, on basal and gonadotrophin-stimulatedprogesterone secretion by isolated subpopulations of both large(granulosa-lutein) and small (theca-lutein) ovine luteal cells.Isolated large and small luteal cells derived from intact, enucleatedovine corpora lutea were incubated for 48–120 h with orwithout 22R-hydroxycholesterol or pregnenolone (2.5 µM)and a range of enclomiphene, zuclomiphene, and/or oestradiolconcentrations (3–100 µM), both with and withoutovine Iuteinizing hormone (100 ng/ml). Spent media were assayedin duplicate for progesterone content by radioimmunoassay. Enclomiphene,zuclomiphene, and oestradiol exhibited equivalent dose-dependentinhibitory effects on basal and gonadotrophin-stimulated smalland large ovine luteal cell progesterone secretion under allsubstrate conditions. Both cell types became more sensitiveto clomiphene inhibition with increasing time in culture. Incombined treatments, the effects of oestradiol and either enclomipheneor zuclomiphene became additive in longer-term cultures andwere never antagonistic In this model system, (i) clomiphene,like oestradiol, appears to inhibit 3-hydroxysteroid dehy-drogenaseactivity, (ii) both stereoisomers act as oestrogen agonists,(iii) neither demonstrates any anti-oestrogenic properties,and (iv) both large and small luteal cells become more sensitiveto clomiphene inhibition with increasing duration of exposure.  相似文献   
993.
To understand the role of CD8+ T cells in experimental autoimmune myasthenia gravis (EAMG), CD8+ T cells were depleted by injecting a monoclonal anti-rat CD8 antibody (OX8) into Lewis rats immunized with Torpedo acetylcholine receptor (AChR) in complete Freund's adjuvant (CFA). CD8-depleted EAMG rats showed strikingly less muscle weakness and lower anti-AChR IgG antibody levels compared to Hy2-15-injected control EAMG rats. Moreover, the numbers of AChR-specific IgG antibody-secreting cells, AChR-reactive interferony-γ-secreting T helper type 1-like cells and lymphocyte proliferation to AChR were lower in the CD8-depleted group than in control EAMG rats. These differences were significant among mononuclear cells from inguinal and popliteal lymph nodes, mesenteric lymph nodes and spleen, but not from thymus when examined 3, 5 and 7 weeks post-immunization. We suggest that CD8+ T cells are involved in the induction and persistance of EAMG by directly or indirectly affecting AChR-reactive T cells and anti-AChR IgG antibody-secreting cells.  相似文献   
994.
Exogenous glucocorticoid hormones are widely used as therapeutical agents, whereas endogenous glucocorticoids may act as physiological immunosuppressants involved in the control of immune and inflammatory responses. The optimal activation of T lymphocytes requires two distinct signals: the major histocompatibility complex-restricted presentation of the antigen and an additional co-stimulatory signal provided by the antigen-presenting cells. There is ample evidence that, among the cells able to present the antigen, the dendritic cells (DC) have the unique property to activate antigen-specific, naive T cells in vitro and in vivo, and are therefore required for the induction of primary immune responses. In this work, we tested whether glucocorticoids affected the capacity of DC to sensitize naive T cells. Our data show that, in vitro, the steroid hormone analog dexamethasone (Dex) affects the viability of DC, selectively downregulates the expression of co-stimulatory molecules on viable DC, and strongly reduces their immunostimulatory properties. In vivo, a single injection of Dex results in impaired antigen presenting function, a finding which correlates with reduced numbers of splenic DC. These results show that glucocorticoids regulate DC maturation and immune function in vitro and in vivo and suggest that this mechanism may play a role in preventing overstimulation of the immune system.  相似文献   
995.
大量的研究表明家蚕丝素蛋白具有良好的生物相容性。而对于柞蚕丝素蛋白在医用生物领域的研究报道在国内外尚较少。本研究选择再生柞蚕丝素蛋白为研究对象,观察了人骨髓间充质干细胞(hBMSCs)在再生柞蚕丝素膜上的粘附、生长及表面抗原的变化。结果在1h观察再生柞蚕丝素对hBMSCs的粘附力几乎与胶原相同,明显优于家蚕丝素和聚苯乙烯培养板。MTT法检测结果显示在第4d hBMSCs在再生柞蚕丝素膜上的增殖明显高于其他各组。电镜观察结果显示hBMSCs在再生柞蚕丝素膜上能够很好的粘附、生长,细胞间能相互连接形成片状结构。流式细胞仪检测再生柞蚕丝素蛋白对hBMSCs表面抗原的表达亦无明显影响。本研究结果显示再生柞蚕丝素蛋白体外支持hBMSCs的粘附、生长,具有良好的细胞相容性。  相似文献   
996.
兔骨髓间充质干细胞来源的心肌(样)细胞的诱导分化研究   总被引:1,自引:0,他引:1  
目的体外诱导骨髓间充质干细胞(Mesenchymal stem cells,MSCs)向肌源性细胞分化,探索诱导后的MSCs移植于心肌梗死区的存活和分化情况。方法提取、分离、培养兔的MSCs。经5-氮胞苷诱导后,进行免疫组化,电镜观察。4',6二乙酞基-2-苯基吲哚(DAPI)标记MSCs,建立兔心肌梗死模型。实验动物随机分两组:实验组(n=10)在心梗区域注入经诱导后的MSCs;对照组(n=10)在心梗区域注入不含MSCs的培养液。移植4周后,进行病理标本观察和免疫组化检测。结果5-氮胞苷诱导MSCs4周,部分细胞表达肌钙蛋白T(troponin T),电镜观察到肌丝形成。MSCs在体外用DAPI标记,用荧光显微镜观察细胞发蓝色荧光。移植4周后,在实验组中用荧光显微镜观察可见梗死区组织标本中可见DAPI标记带蓝色荧光的供体细胞核,移植细胞表达troponin T。结论MSCs经5-氮胞苷诱导后可向心肌细胞转化。移植细胞可在心肌存活,并向心肌细胞(样)转化。  相似文献   
997.
 目的 探讨可溶性 HLA-G1(sHLA-G1)对人 NK-92 细胞杀伤活性的抑制与细胞表面免疫球蛋白样转录分子 2(ILT2)和杀伤细胞免疫球蛋白样受体 2DL4(KIR2DL4)受体的关系。 方法 ①通过原核表达技术获得 sHLA-G1 重组蛋白(重组蛋白),并采用蛋白质印迹法进行鉴定。②取 NK-92 细胞,加入终浓度 20 μg/ml 的重组蛋白分别培养 10、30 min,再分别加入抗 HLA-G1/G5、抗ILT2 和抗 KIR2DL4 抗体,采用流式细胞术检测各组 NK-92 细胞表面 sHLA-G1 和 ILT2、KIR2DL4 受体表达阳性率;以 NK-92 细胞单独培养作为对照组。③以人白血病 K562 细胞为靶细胞,以经不同方式处理的 NK-92 细胞为效应细胞,效靶比为5:1,共同培养 2 h,采用流式细胞术检测 NK-92 细胞对 K562 细胞的杀伤率。NK-92 细胞处理方式为单纯重组蛋白处理(分别加入终浓度为 0、10、20 μg/ml 的重组蛋白培养 30 min)和表面受体封闭 + 重组蛋白处理(分别加入抗 ILT2、抗 KIR2DL4、抗 LT2 + 抗 KIR2DL4 抗体培养 30 min,再分别加入终浓度为 0、10、20 μg/ml 的重组蛋白培养 30 min)。 结果 ①蛋白质印迹分析表明所获重组蛋白为带有组氨酸标签的特异蛋白。②NK-92 细胞与 20 μg/ml 重组蛋白共培养 30 min 后,sHLA-G1 表达阳性率明显高于而 ILT2、KIR2DL4 受体表达阳性率均明显低于对照组(均 P < 0.05)。③以终浓度 0、10、20 μg/ml 的重组蛋白处理的 NK-92 细胞对 K562 细胞的杀伤率分别为 39.79% ± 2.00%、27.79% ± 0.75%、21.36% ± 0.67%(两两比较,均 P < 0.01);单独封闭 ILT2 受体,杀伤率分别为 23.09% ± 1.63%、21.13% ± 0.38%、18.42% ± 0.47%(两两比较,均 P < 0.01);单独封闭 KIR2DL4 受体,杀伤率分别为 30.74% ± 0.44%、26.03% ± 0.38%、21.15% ± 0.35%(两两比较,均 P < 0.01)。 结论 sHLA-G1 通过与 NK-92 细胞表面 ILT2 和 KIR2DL4 受体直接结合而抑制 NK-92 细胞的杀伤活性。  相似文献   
998.
目的:探讨终末糖基化产物在糖尿病动脉粥样硬化(AS)形成中的作用机理。 方法: 分离正常人脐静脉内皮细胞(HUVECs),将终末糖基化终产物(AGE)修饰的人血清白蛋白(AGE-HSA)、人血清白蛋白(HSA)与HUVECs在体外共同培养,并用荧光单克隆抗体染色,流式细胞仪定量检测细胞间粘附分子-1(ICAM-1)、血管细胞粘附分子-1(VCAM-1)的表达。 结果: 正常人HUVEC表达ICAM-1和VCAM-1。AGE-HSA能以时间和剂量依赖的方式上调ICAM-1、VCAM-1的表达(P<0.05),而HSA对HUVECs上述粘附分子的表达均无影响。 结论: AGE能上调HUVECs粘附分子的表达,从而促进AS时单核/巨噬细胞的浸润。  相似文献   
999.
目的比较腺病毒载体(Ad)介导人和小鼠酪氨酸酶相关蛋白2(tyrosinase-relatedpro-tein2,TRP2)修饰小鼠骨髓来源的树突状细胞(BM-DC)诱发抗小鼠黑色素瘤免疫的差异。方法Ad编码人或小鼠TRP2(AdhTRP2或AdmTRP2)体外感染小鼠BM-DC并体内皮下免疫C57BL/6小鼠,7d后取出被免疫小鼠脾细胞行体内细胞毒性T淋巴细胞杀伤试验(invivoCTL)和细胞内IFN-γ染色(ICS)分析CTL的杀伤活性和IFN-γ的产生;或给免疫后小鼠皮下接种小鼠B16.F10黑色素瘤细胞,观察荷瘤小鼠的成活情况。结果invivoCTL和ICS分析显示,AdhTRP2/BM-DC免疫小鼠,其6hCTL杀伤率为(98.7±1.2)%,IFN-γ产生的CD8+T细胞占总CD8+T细胞的(1.25±0.21)%;而AdmTRP2/BM-DC免疫的小鼠,其6hCTL杀伤率和产生IFN-γ的CD8+T细胞比例分别为(28.6±6.3)%和(0.24±0.06)%。荷瘤试验表明,AdhTRP2/BM-DC免疫小鼠后1周皮下接种106B16.F10细胞,观察3个月100%的小鼠无瘤生长;而接种5×104B16.F10细胞至AdmTRP2/BM-DC免疫1周的小鼠,3个月后小鼠成活率仅为40%。结论Ad介导异种(人)TRP2较自身(小鼠)TRP2修饰的BM-DC更为有效地打破肿瘤免疫耐受、诱导强烈的抗黑色素瘤免疫反应,是一种高效的以DC为基础的肿瘤疫苗。  相似文献   
1000.
Based on animal models and limited clinical experience, there is considerable interest in use of high-dose immunosuppression followed by hemopoietic stem cell transplantation as treatment for severe rheumatoid arthritis. Because of its relatively low treatment-related mortality and morbidity, autologous transplantation is a more attractive option than allogeneic transplantation for initial clinical trials, even though anecdotal reports suggest that allogeneic transplantation has a greater likelihood of bringing about long-term disease control. The approach remains experimental with many unanswered questions such as the value and safety of high-dose therapy without transplantation, the need for T cell purging, the possible deleterious effects of post-transplant hemopoietic growth factors and the potential of mini allogeneic transplantation (a process whereby intense immunosuppression is combined with less intense myelosuppression). To achieve quick progress it is essential that clinical trials be carefully designed with all cases being reported to the Autoimmune Disease Stem Cell Project Database.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号